Translate this page into:
Management of peripheral arterial occlusive disease in resource-limited settings: A narrative review
*Corresponding author: Dr Suraj Pai, Associate Professor, Department of Cardiovascular and Thoracic Surgery, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Karnataka, India drpaisuraj@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Pai S, Pai S, Hegde SR. Management of peripheral arterial occlusive disease in resource-limited settings: A narrative review. South Asian J Health Sci. doi: 10.25259/SAJHS_23_2026
Abstract
Peripheral arterial occlusive disease (PAOD) is a manifestation of systemic atherosclerosis associated with substantial morbidity, limb loss, and increased cardiovascular mortality. Its burden is rapidly increasing in lowand middle-income countries, where healthcare delivery is constrained by limited infrastructure, workforce shortages, and financial barriers. Patients in such settings frequently present late with advanced ischemia, reflecting gaps in awareness, screening, and access to timely care. This review synthesises current evidence on epidemiology, pathophysiology, diagnosis, and management of PAOD, with a focus on pragmatic, cost-effective strategies suitable for resource-limited environments. Particular emphasis is placed on strengthening primary care, leveraging community-based interventions, and integrating telemedicine to improve outcomes.
Keywords
Limb ischemia
Peripheral arterial disease
Resource-limited settings
Rural health
Vascular disease
INTRODUCTION
Peripheral arterial occlusive disease (PAOD), also known as peripheral arterial disease (PAD), is characterised by progressive atherosclerotic narrowing of the peripheral arteries, most commonly involving the lower extremities. It is a clinical marker of systemic atherosclerosis and is strongly associated with coronary artery disease and cerebrovascular disease, conferring a high risk of major adverse cardiovascular events.[1] While advances in pharmacotherapy and revascularisation have improved outcomes in high-resource settings, these benefits are not equitably distributed.
In resource-limited environments, structural and socioeconomic barriers impede early detection and optimal management. Consequently, patients often present with advanced disease such as critical limb ischemia (CLI), which is associated with high rates of amputation and mortality.[2]Addressing PAOD in these settings requires context-sensitive strategies that prioritise affordability, accessibility, and scalability.
EPIDEMIOLOGY AND GLOBAL BURDEN
The global prevalence of PAOD exceeds 200 million individuals and continues to rise due to population ageing and the increasing prevalence of diabetes mellitus, hypertension, and tobacco use.[3] Notably, the greatest relative increases have been observed in low- and middle-income countries, where rapid epidemiological transition has outpaced healthcare system capacity.
In resource-limited settings, the true burden of disease is likely underestimated because of inadequate screening and diagnostic capabilities. Many individuals remain asymptomatic or are misdiagnosed until they develop complications such as non-healing ulcers or gangrene. Late presentation is a consistent feature and is associated with worse limb and survival outcomes.[4]
PATHOPHYSIOLOGY
PAOD results from a complex interplay of endothelial dysfunction, lipid accumulation, inflammation, and thrombosis, leading to atherosclerotic plaque formation and arterial stenosis. Progressive luminal narrowing reduces perfusion to distal tissues, particularly during exertion, resulting in ischemic symptoms. Over time, collateral circulation may develop but is often insufficient to meet metabolic demands.
At advanced stages, critical reductions in blood flow lead to rest pain, tissue necrosis, and gangrene. Inflammatory pathways and prothrombotic states further exacerbate disease progression and increase the risk of acute limb ischemia. These processes are often accelerated in patients with diabetes and chronic kidney disease.[5]
RISK FACTORS
The principal risk factors for PAOD include diabetes mellitus, tobacco use, hypertension, dyslipidaemia, and advanced age. In resource-limited settings, these risk factors are frequently poorly controlled due to limited access to preventive healthcare services and medications. Tobacco use remains particularly prevalent in many rural communities, and diabetes is often undiagnosed or inadequately managed [Table 1].
| Risk factor | Mechanism/impact on PAOD | Relevance in resource-limited settings |
|---|---|---|
| Diabetes mellitus | Accelerates atherosclerosis and microvascular damage | Often poorly controlled due to limited access to care |
| Smoking | Endothelial damage, increased thrombosis | High prevalence, low cessation support |
| Hypertension | Vascular wall stress and damage | Frequently undiagnosed/untreated |
| Dyslipidemia | Plaque formation and progression | Limited screening and statin access |
| Advanced age | Degenerative vascular changes | Increasing elderly population |
POAD: Peripheral arterial occlusive disease
Compounding these issues are low levels of health literacy and limited awareness of vascular disease, which contribute to delayed health-seeking behaviour. Socioeconomic constraints and competing health priorities further hinder effective risk factor modification.[6]
CHALLENGES IN RESOURCE-LIMITED SETTINGS
The management of PAOD in resource-constrained environments is complicated by multiple systemic and patient-level barriers. Diagnostic limitations are a major concern, as simple tools such as the ankle-brachial index (ABI) are not routinely available in many primary care settings. Even when equipment exists, a lack of trained personnel can limit its effective use.
Geographic and financial barriers significantly restrict access to healthcare facilities, particularly specialised vascular services. Patients may need to travel long distances to reach tertiary centres, incurring substantial out-of-pocket expenses. In addition, fragmented referral pathways often result in delays in receiving definitive care.
Cultural beliefs and reliance on traditional remedies can further delay presentation. As a result, many patients present with advanced disease requiring complex interventions that are often unavailable or unaffordable. Limited availability of revascularisation procedures and essential medications compounds the problem, leading to high rates of preventable amputations.[7]
DIAGNOSIS
Accurate and timely diagnosis of PAOD is critical for preventing disease progression and complications. In resource-limited settings, clinical evaluation remains the cornerstone of diagnosis. A detailed history focusing on exertional leg pain, rest pain, and non-healing wounds, combined with physical examination findings such as diminished pulses and trophic skin changes, can provide valuable diagnostic clues [Table 2].
| Modality | Utility | Advantages | Limitations |
|---|---|---|---|
| Clinical examination | Initial screening | No cost, widely available | Low sensitivity in early disease |
| Ankle-brachial index | Confirms diagnosis | Cost-effective, simple | Requires doppler and training |
| Handheld doppler | Measures arterial flow | Portable, relatively cheap | Operator dependent |
| Duplex ultrasound | Assesses anatomy and flow | Non-invasive, informative | Limited availability |
| CT/MR angiography | Detailed vascular imaging | Accurate | Expensive, limited access |
PAOD: Peripheral arterial occlusive disease, CT: Computed tomography, MR: Magnetic resonance.
The ABI is a simple, non-invasive, and cost-effective diagnostic tool that can be implemented even in low-resource settings. An ABI value of less than 0.9 is indicative of PAOD and correlates with disease severity.[7] Handheld Doppler devices, which are relatively affordable, can facilitate ABI measurement at the primary care level.
Advanced imaging modalities such as duplex ultrasonography, computed tomography angiography, and magnetic resonance angiography provide detailed anatomical information but are often limited to higher-level facilities. Establishing referral linkages for selected patients can optimise the use of these resources.
MANAGEMENT STRATEGIES
Risk factor modification
Effective management of PAOD begins with aggressive modification of cardiovascular risk factors. Smoking cessation is one of the most impactful interventions, significantly reducing disease progression and improving outcomes. Glycaemic control in diabetic patients is essential to prevent microvascular and macrovascular complications. Similarly, optimal management of hypertension and dyslipidaemia through lifestyle changes and pharmacotherapy reduces both limb-related and cardiovascular events.[8]
Pharmacological therapy
Pharmacological treatment plays a central role in the management of PAOD. Antiplatelet agents such as aspirin or clopidogrel are recommended to reduce the risk of cardiovascular events [Table 3]. Statins not only lower lipid levels but also stabilise atherosclerotic plaques and improve endothelial function, thereby enhancing limb outcomes. Cilostazol, where available, can improve walking distance in patients with intermittent claudication, although its use may be limited by cost and availability.[9]
| Step | Intervention category | Key measures | Feasibility in low-resource settings |
|---|---|---|---|
| 1 | Risk factor modification | Smoking cessation, BP, glucose, lipid control | High |
| 2 | Pharmacotherapy | Antiplatelets, statins, cilostazol | Moderate |
| 3 | Exercise therapy | Walking programs, home-based exercise | High |
| 4 | Wound care | Dressing, infection control, and offloading | High |
| 5 | Revascularization | Endovascular/surgical referral | Low–moderate |
| 6 | Telemedicine | Remote consultation, follow-up | Increasing feasibility |
PAOD: Peripheral arterial occlusive disease, BP: Blood pressure.
Exercise therapy
Exercise therapy is a cornerstone of non-invasive management, particularly for patients with intermittent claudication. Supervised exercise programs have demonstrated significant benefits in improving walking distance and quality of life. However, such programs are rarely available in resource-limited settings. Community-based walking initiatives and patient education on structured home-based exercise regimens represent practical and scalable alternatives.[9]
Wound care and limb preservation
In patients presenting with ulcers or tissue loss, meticulous wound care is essential. This includes regular cleaning, appropriate dressings, infection control, and offloading of pressure areas. Training primary healthcare workers in basic wound care techniques can significantly reduce complications and prevent progression to amputation. Early identification of infection and timely antibiotic use are critical components of limb preservation.
Revascularization
Revascularisation is indicated in patients with severe symptoms or CLI. Endovascular procedures such as angioplasty are less invasive and associated with shorter recovery times, but require specialised equipment and expertise that may not be available in rural settings. Surgical bypass remains an option in selected cases, but it is resource-intensive and requires postoperative care infrastructure.
In many resource-limited environments, timely referral systems are crucial to ensure that patients who may benefit from revascularisation are identified early and transferred appropriately. When limb salvage is not possible, amputation may be necessary; however, early intervention can significantly reduce its incidence.
Telemedicine and task-shifting
Telemedicine has emerged as a valuable tool for improving access to specialist care in underserved areas. Remote consultations can assist primary care providers in diagnosis and management decisions, reducing delays in care. Task-shifting, which involves training non-specialist healthcare workers to perform specific tasks, can enhance service delivery and extend the reach of vascular care in resource-limited settings.[10]
COST-EFFECTIVE STRATEGIES
Cost-effective approaches are essential for sustainable PAOD management in low-resource environments. The use of affordable diagnostic tools such as handheld Doppler devices enables early detection at the primary care level. Community screening programs integrated with existing non-communicable disease initiatives can increase case identification.
Training frontline healthcare workers in risk factor management, wound care, and patient education can significantly improve outcomes at minimal cost. Public health interventions targeting smoking cessation and diabetes control are also critical components of a comprehensive strategy.
ROLE OF PRIMARY CARE
Primary care systems play a pivotal role in addressing PAOD in resource-limited settings. Early detection, initiation of medical therapy, and ongoing risk factor management can all be effectively delivered at this level. Strengthening primary healthcare infrastructure, ensuring the availability of essential medications, and enhancing provider training are key priorities.
FUTURE DIRECTIONS
Future efforts should focus on developing low-cost diagnostic technologies and expanding telemedicine networks to improve access to care. Policy initiatives aimed at strengthening health systems and addressing social determinants of health are essential. Increased investment in rural healthcare infrastructure and workforce development will be critical for reducing disparities in PAOD outcomes.
CONCLUSION
Peripheral arterial occlusive disease represents a growing public health challenge in resource-limited settings. A pragmatic approach that emphasises prevention, early diagnosis, and cost-effective management strategies is essential. Strengthening primary care systems, improving access to essential services, and leveraging innovative solutions such as telemedicine can substantially improve patient outcomes and reduce the burden of disease.
Authors’ contribution:
SP, SRH: Conceptualization, methodology, software, validation, formal analysis, investigation, resources, data curation, writing - original draft, writing - review & editing, visualization, supervision, project administration, funding acquisition.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
Patient’s consent not required as there are no patients in this study.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that they have used artificial intelligence (AI)-assisted technology to refine language of the manuscript.
Financial support and sponsorship: Nil.
References
- 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary. Circulation. 2017;135:e686-725.
- [CrossRef] [Google Scholar]
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet. 2013;382:1329-40.
- [CrossRef] [PubMed] [Google Scholar]
- Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020-30.
- [CrossRef] [PubMed] [Google Scholar]
- Major adverse limb events and mortality in patients with peripheral artery disease: The COMPASS trial. J Am Coll Cardiol. 2018;71:2306-15.
- [CrossRef] [PubMed] [Google Scholar]
- Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129-38.
- [CrossRef] [PubMed] [Google Scholar]
- Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371:818-27.
- [CrossRef] [PubMed] [Google Scholar]
- Delay in diagnosis and treatment of peripheral artery disease in patients with diabetes mellitus. Vasc Med. 2015;20:319-26.
- [Google Scholar]
- Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 2004;40:1158-65.
- [CrossRef] [PubMed] [Google Scholar]
- Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;12:CD000990.
- [CrossRef] [PubMed] [Google Scholar]
- Evaluating barriers to adopting telemedicine worldwide: A systematic review. BMJ Open. 2018;8:e018153.
- [Google Scholar]

